Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Conditions
Ovarian Cancer · Fallopian Tube Cancer · Peritoneal Neoplasms · Endometrial Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
004, Birmingham, Alabama, United States
150, Palo Alto, California, United States
014, San Francisco, California, United States
544, Fort Myers, Florida, United States
335, Miami Beach, Florida, United States
543, West Palm Beach, Florida, United States
518, Minneapolis, Minnesota, United States
334, Kansas City, Missouri, United States
521, St Louis, Missouri, United States
292, Albuquerque, New Mexico, United States
304, Centerville, Ohio, United States
517, Eugene, Oregon, United States
127, Pittsburgh, Pennsylvania, United States
522, Fairfax, Virginia, United States
300, Norfolk, Virginia, United States
121, Milwaukee, Wisconsin, United States
328, Aalst, Belgium, Belgium
326, Charleroi, Belgium
325, Hasselt, Belgium
108, Leuven, Belgium
306, Lille, France
307, Nancy, France
310, Nice, France
324, Pierre-Bénite, France
323, Plérin, France
308, Toulouse, France
519, Aachen, Germany
255, Berlin, Germany
520, Kempten, Germany
321, Catania, Italy
122, Milan, Italy
516, Milan, Italy
295, Pavia, Italy
124, Rome, Italy
293, Torino, Italy
319, Treviso, Italy
341, Gdynia, Poland
329, Siedlce, Poland
396, Seoul, Gangnam-gu, South Korea
397, Gyeonggi-do, Goyang-si, South Korea
399, Seoul, Jongno-gu, South Korea
523, Seoul, Seocho-gu, South Korea
398, Seoul, Seodaemun-gu, South Korea
403, Seoul, Songpa-gu, South Korea
349, Badalona, Spain
115, Barcelona, Spain
114, Madrid, Spain
558, Valencia, Spain
330, Valencia, Spain
Study leads
Danny Nguyen, MD
Study Director
Corcept Therapeutics